Cargando…
Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia
Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219492/ https://www.ncbi.nlm.nih.gov/pubmed/34221541 http://dx.doi.org/10.14336/AD.2021.0229 |
_version_ | 1783710939539832832 |
---|---|
author | Nizamutdinov, Damir Qi, Xiaoming Berman, Marvin H Dougal, Gordon Dayawansa, Samantha Wu, Erxi Yi, S. Stephen Stevens, Alan B Huang, Jason H |
author_facet | Nizamutdinov, Damir Qi, Xiaoming Berman, Marvin H Dougal, Gordon Dayawansa, Samantha Wu, Erxi Yi, S. Stephen Stevens, Alan B Huang, Jason H |
author_sort | Nizamutdinov, Damir |
collection | PubMed |
description | Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and potential therapeutic benefits of tNIR light stimulations in the treatment of dementia. Patients of mild to moderate dementia were randomized into active and sham treatment groups at 2:1 ratio. Active treatment consisted of low power tNIR light stimulations with an active photobiomodulation for 6 min twice daily during 8 consequent weeks. Sham treatment consisted of same treatment routine with a sham device. Neuropsychological battery was obtained before and after treatment. Analysis of variance (ANOVA) was used to analyze outcomes. Sixty subjects were enrolled. Fifty-seven subjects completed the study and had not reported health or adverse side effects during or after the treatment. Three subjects dropped out from trial for health issues unrelated to use of tNIR light treatment. Treatment with active device resulted in improvements of cognitive functions and changes were: an average increase of MMSE by 4.8 points; Logical Memory Tests I and II by ~3.0 points; Trail Making Tests A and B by ~24%; Boston Naming Test by ~9%; improvement of both Auditory Verbal Learning Tests in all subtest categories and overall time of performance. Many patients reported improved sleep after ~7 days of treatment. Caregivers noted that patients had less anxiety, improved mood, energy, and positive daily routine after ~14-21 days of treatment. The tNIR light treatments demonstrated safety and positive cognitive improvements in patients with dementia. Developed treatment protocol can be conveniently used at home. This study suggests that additional dementia treatment trials are warranted with a focus on mitigating caregivers’ burden with tNIR light treatment of dementia patients. |
format | Online Article Text |
id | pubmed-8219492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | JKL International LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-82194922021-07-03 Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia Nizamutdinov, Damir Qi, Xiaoming Berman, Marvin H Dougal, Gordon Dayawansa, Samantha Wu, Erxi Yi, S. Stephen Stevens, Alan B Huang, Jason H Aging Dis Short Communications Dementia is a complex syndrome with various presentations depending on the underlying pathologies. Low emission of transcranial near-infrared (tNIR) light can reach human brain parenchyma and be beneficial to a number of neurological and neurodegenerative disorders. We hereby examined the safety and potential therapeutic benefits of tNIR light stimulations in the treatment of dementia. Patients of mild to moderate dementia were randomized into active and sham treatment groups at 2:1 ratio. Active treatment consisted of low power tNIR light stimulations with an active photobiomodulation for 6 min twice daily during 8 consequent weeks. Sham treatment consisted of same treatment routine with a sham device. Neuropsychological battery was obtained before and after treatment. Analysis of variance (ANOVA) was used to analyze outcomes. Sixty subjects were enrolled. Fifty-seven subjects completed the study and had not reported health or adverse side effects during or after the treatment. Three subjects dropped out from trial for health issues unrelated to use of tNIR light treatment. Treatment with active device resulted in improvements of cognitive functions and changes were: an average increase of MMSE by 4.8 points; Logical Memory Tests I and II by ~3.0 points; Trail Making Tests A and B by ~24%; Boston Naming Test by ~9%; improvement of both Auditory Verbal Learning Tests in all subtest categories and overall time of performance. Many patients reported improved sleep after ~7 days of treatment. Caregivers noted that patients had less anxiety, improved mood, energy, and positive daily routine after ~14-21 days of treatment. The tNIR light treatments demonstrated safety and positive cognitive improvements in patients with dementia. Developed treatment protocol can be conveniently used at home. This study suggests that additional dementia treatment trials are warranted with a focus on mitigating caregivers’ burden with tNIR light treatment of dementia patients. JKL International LLC 2021-07-01 /pmc/articles/PMC8219492/ /pubmed/34221541 http://dx.doi.org/10.14336/AD.2021.0229 Text en copyright: © 2021 Nizamutdinov et al. https://creativecommons.org/licenses/by/2.0/this is an open access article distributed under the terms of the creative commons attribution license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Short Communications Nizamutdinov, Damir Qi, Xiaoming Berman, Marvin H Dougal, Gordon Dayawansa, Samantha Wu, Erxi Yi, S. Stephen Stevens, Alan B Huang, Jason H Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title | Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title_full | Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title_fullStr | Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title_full_unstemmed | Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title_short | Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia |
title_sort | transcranial near infrared light stimulations improve cognition in patients with dementia |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219492/ https://www.ncbi.nlm.nih.gov/pubmed/34221541 http://dx.doi.org/10.14336/AD.2021.0229 |
work_keys_str_mv | AT nizamutdinovdamir transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT qixiaoming transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT bermanmarvinh transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT dougalgordon transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT dayawansasamantha transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT wuerxi transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT yisstephen transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT stevensalanb transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia AT huangjasonh transcranialnearinfraredlightstimulationsimprovecognitioninpatientswithdementia |